Page 28 - Journal of Structural Heart Disease Volume 4, Issue 2

49
Case Report
Video 15. TTE 2D long axis view of the aortic valve post-dilation demonstrating reduction in perivalvular regurgitation. View sup- plemental video at https://doi.org/10.12945/j.jshd.2018.042.17. vid.15.
ly clinical testing for the treatment of primary AR and are equipped with an anchoring system that serves to stably and accurately position the valves in patients with predominant AR to prevent the migration and resultant perivalvular regurgitation seen in this study [3, 4]. These new platforms will expand the use of TAVR in ACHD patients to further decrease the need for repeat surgeries in this patient population. To our knowledge, this is the rst published case of tran- scatheter deployment of an Edwards Sapien-3 valve in the aortic position in a patient with D-TGA post sta- tus arterial switch with predominant AR.
In conclusion, TAVR in patients with congenital heart disease and pulmonary conduit or bioprosthet- ic valve dysfunction has become the new standard of care. These minimally invasive and e ective tech-
Video 16. TTE 2D short axis view of the aortic valve post-dila- tion demonstrating reduction in the perivalvular regurgita- tion. View supplemental video at https://doi.org/10.12945/j. jshd.2018.042.17.vid.16.
niques have allowed for a reduction in the number of open cardiac surgeries needed over the lifetime of a CHD patient. Advances in technology are increasing the applications of TAVR in lesions that were previ- ously only surgically treated. TAVR in ACHD patients with predominant AR is a new frontier, and the use of the newer-generation valves may prove promising.
Con ict of Interest
The authors have no con ict of interest relevant to this publication.
Comment on this Article or Ask a Question
References
1. Bauer T, Linke A, Sievert H, Kahlert P, Ham- brecht R, Nickenig G, et al. Comparison of the e ectiveness of transcatheter aortic valve implantation in patients with stenot- ic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am J Cardiol. 2014;113:518-521. DOI: 10.1016/j. amjcard.2013.10.023
2. Yoon SH, Lefevre T, Ahn JM, Perlman GY, Dvir D, Latib A, et al. Transcatheter aortic valve replacement with early- and new-genera- tion devices in bicuspid aortic valve steno-
sis. J Am Coll Cardiol. 2016;68:1195-1205.
DOI: 10.1016/j.jacc.2016.06.041
3. Kumar R, Latib A, Colombo A, Ruiz CE. Self-expanding prostheses for transcathe- ter aortic valve replacement. Prog Cardio- vasc Dis. 2014;56:596-609. DOI: 10.1016/j.
pcad.2014.03.002
4. Treede H, Rastan A, Ferrari M, Ensminger S, Figulla H-R, Mohr F-W. JenaValve. EuroInt- ervention. 2012;8 Suppl Q:Q88-Q93. DOI: 10.4244/eijv8sqa16
Cite this article as: Ghobrial J, Yang EH, Aksoy O, Suh W, Aboulhosn J. Tran- scatheter Aortic Valve Replacement in Transposition of the Great Arteries Following Arterial Switch Operation. Structural Heart Disease. 2018;4(2):42- 49. DOI: https://doi.org/10.12945/j. jshd.2018.042.17
Ghobrial J. et al.
TAVR in TGA